Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Thalidomide in Recurrent Glioblastoma
NCT00006358Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2000
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00006358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006358.